Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jid.2021.01.025 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Amelanotic B16-F10 Melanoma Compatible with Advanced Three-Dimensional Imaging Modalities.
J Invest Dermatol
August 2021
Immune Imaging Program, Centenary Institute, Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
Imaging of Experimental Melanoma Tumors using the Novel Radiotracer Ga-NODAGA-Procainamide (PCA).
J Cancer
February 2017
Department of Medical Imaging, Nuclear Medicine, University of Debrecen, Debrecen, Hungary;; Scanomed LTD, Debrecen, Hungary.
Purpose: The most aggressive form of skin cancer is the malignant melanoma. Because of its high metastatic potential the early detection of primary melanoma tumors and metastases using non-invasive PET imaging determines the outcome of the disease. Previous studies have already shown that benzamide derivatives, such as procainamide (PCA) specifically bind to melanin pigment.
View Article and Find Full Text PDFComparative preclinical evaluation of Ga-NODAGA and Ga-HBED-CC conjugated procainamide in melanoma imaging.
J Pharm Biomed Anal
May 2017
Department of Medical Imaging, Nuclear Medicine, University of Debrecen, Debrecen, Hungary.
Malignant melanoma is the most aggressive form of skin cancer. The early detection of primary melanoma tumors and metastases using non-invasive PET imaging determines the outcome of this disease. Previous studies have shown that benzamide derivatives (e.
View Article and Find Full Text PDFPeroxisome proliferator-activated receptor α (PPARα) contributes to control of melanogenesis in B16 F10 melanoma cells.
Arch Dermatol Res
April 2017
Department of Biophysics, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, ul. Gronostajowa 7, 30-387, Kraków, Poland.
Recent studies revealed the cooperation between peroxisome proliferator-activated receptor gamma (PPARγ) and α-MSH signaling, which results in enhanced melanogenesis in melanocytes and melanoma cells. However, the agonists of PPARα, such as fenofibrate, exert depigmenting effect. Therefore, we aimed to check how the PPARα expression level affects the antimelanogenic activity of fenofibrate and whether PPARα modulates melanogenesis independently of its agonist.
View Article and Find Full Text PDFStructure-toxicity relationship of phenolic analogs as anti-melanoma agents: an enzyme directed prodrug approach.
Chem Biol Interact
February 2010
Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, 1406 Coulter Drive, Amarillo, TX 79106, USA.
The aim of this study was to identify a phenolic prodrug compound that is minimally metabolized by rat liver microsomes, but yet could form quinone reactive intermediates in melanoma cells as a result of its bioactivation by tyrosinase. In current work, we investigated 24 phenolic compounds for their metabolism by tyrosinase, rat liver microsomes and their toxicity towards murine B16-F0 and human SK-MEL-28 melanoma cells. A linear correlation was found between toxicities of phenolic analogs towards SK-MEL-28 and B16-F0 melanoma cells, suggesting similar mechanisms of toxicity in both cell lines.
View Article and Find Full Text PDF